Scopus
🔓 Açık Erişim YÖKSİS Eşleşti
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU
Allergy European Journal of Allergy and Clinical Immunology · Şubat 2020
YÖKSİS Kayıtları
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU
ALLERGY · 2020 SCI
DOÇENT KEMAL EROL →
Makale Bilgileri
DergiAllergy European Journal of Allergy and Clinical Immunology
Yayın TarihiŞubat 2020
Cilt / Sayfa75 · 468-470
Scopus ID2-s2.0-85073978690
Erişim🔓 Açık Erişim
Yazarlar (7)
1
Ragıp Ertaş
2
Tomasz Hawro
3
Sabine Altrichter
ORCID: 0000-0001-9955-385X
4
Kemal Özyurt
ORCID: 0000-0002-6913-8310
5
Kemal Erol
ORCID: 0000-0003-0673-3961
6
Şule Ketenci Ertaş
ORCID: 0000-0002-1519-3445
7
Marcus Maurer
ORCID: 0000-0002-4121-481X
Kurumlar
Charité – Universitätsmedizin Berlin
Berlin Germany
Erciyes Üniversitesi
Kayseri Turkey
Kayseri City Hospital
Kayseri Türkiye
Metrikler
26
Atıf
7
Yazar